Celebrate American Heart Month in FebruaryJanuary 31st, 2019
Global ELISA Market to Grow at a CAGR of 5.5% through 2028January 30th, 2019
MEDICA 2019 - World Forum for Medicine
Düsseldorf, GermanyBooth No.: 3/D35-2
AACC Annual Scientific Meeting and Clinical Lab Expo
Anaheim Convention Center ~ Anaheim, CABooth No.: 2627
Thanks to Block Scientific, I was able to procure the re-certified Bayer DCA 2000+ without hassles and get the lab back in operation. The
device works perfectly and I look forward to doing more business with Block Scientific.
--- Mathew Anderson, New Jersey
For the qualitative screening of serum IgG antibodies to Entamoeba histolytica using an Enzyme Linked Immunoabsorbant Assay (ELISA) technique.
Amebiasis is the disease caused by the protozoan parasite Entamoeba histolytica. This organism is endemic throughout the world in developing countries, and can be found in immigrants and travelers from these areas. The disease usually manifests with intestinal symptoms. In a minority of cases, the organism will become extra-intestinal and lead to abscess formation in
different organs. Of the organs that could be affected, the liver is the most common site.
Typically, the organism can no longer be found in the feces once the disease goes extra-intestinal. Serological tests are useful in detecting infection by E.histolytica if the organism goes extra-intestinal and in excluding the organism from the diagnosis of other disorders (e.g.
chronic liver diseases, ulcerative colitis, etc.). This serology test should not be used for detecting intestinal infections.
An Ova & Parasite (O&P) test or an E. histolytica fecal antigen assay is the proper assay for intestinal infections. Since antibodies may persist for years after clinical cure, a positive serological result may not necessarily indicate an active infection. A negative serological result however can be equally important in excluding suspected tissue invasion by E.histolytica.